Personalizing the supply chain
Executing the logistics of cell and gene therapies is a challenge like no other—after all, if you cannot deliver the therapy to the patient, its efficacy is irrelevant, as the patient receives no benefit. For your patients, the stakes have never been higher. As your logistics partner, our record of flawless execution has never been more valuable. Discover how to partner with World Courier and access our global logistics platform.
Managing ultra-complex timing
Flawless planning and execution
Because cell and gene therapies involve living cells there can be extremely limited shelf lives, so timely transport is, quite plainly, a matter of life or death. Collaborative assessment and study design are just the beginning. We partner with key stakeholders in study-specific SOPs, extensive contingency planning and transparency to ensure unexpected complications don’t impact your delivery. Some might call it excessive. We call it reliability your research and patients can trust.
Download our e-book to learn more about our logistics platform
Vein-to-vein support
Logistics: scale from clinical to commercial
As cell and gene therapies move through clinical trials and advance toward a commercial launch, innovators must overcome unprecedented challenges. In many cases, this will require redefining established approaches within many areas of commercialization. Together with industry-leading partners across the AmerisourceBergen enterprise, we offer end-to-end commercialization strategies for making this new, patient-centered logistics model scalable.
Read our white paper: Commercializing Cell and Gene Therapies
In a recent phase II cell therapy study, we delivered:
245
THERAPY-critical shipments
39
global destinations
100%
on-time delivery TO SITES
E-book - Tomorrow's Medicine: Curing One Patient at a Time
Transporting hope
When a 3-year-old girl was diagnosed with Sanfilippo syndrome—a rare “childhood Alzheimer’s” that would gradually rob her of language, mobility, and eventually her life—there was no known cure. Still, her family spent two years in voluntary quarantine to prepare for an experimental gene therapy study with the potential to cure her disease. Read more about how we support these potentially groundbreaking treatments in our e-book, “Curing One Patient at a Time.”
Download the e-book
Helping realize the promise of cell and gene therapies
Leveraging the power of our global network
Best-in-class temperature control solutions
Unmatched temperature stability
In the world of cell and gene therapy transport, success requires diverse, reliable solutions. A single treatment might require both controlled-ambient and cryogenically-frozen shipments within the same supply loop. With empirically-backed expertise in all conditions for shipping, we can build a robust and flexible partnership with your clinical and commercial operations team to create truly customized temperature-controlled shipping solutions that help patients access life-changing treatment.
View temperature control solutions
Partnerships built on experience
What do we bring to a partnership? In a word, ‘experience.’ Experience in all the areas that extend beyond the patient or microscope and are not innate to the clinical team. Experience with airlines and customs in every part of the world. With permits and licensing requirements in a dynamic global regulatory environment. As a partner in your study, we bring experience managing thousands of details to enable the successful completion of every shipment.
